ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.

Katerina Bouchalova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.